Measures · C09 in 2022 · Part C · HD2 Managing Chronic (Long Term) Conditions
Diabetes Care – Eye Exam
Chronic ConditionsHealth PlanSource: HEDIS
- What it measures
- Percent of plan members with diabetes who had an eye exam to check for damage from diabetes during the year.
- How it's calculated
- The percentage of diabetic MA enrollees 18-75 with diabetes (type 1 and type 2) (denominator) who had an eye exam (retinal) performed during the measurement year (numerator).
- Data source
- HEDIS
- Measurement period
- 01/01/2020 – 12/31/2020
- Better when
- Higher
- Weight
- 1 (Process Measure)
- Star assignment
- Clustering
- Case-mix adjusted
- No
- In improvement measure
- Yes
- Used in CAI
- Yes
- HEDIS label
- Comprehensive Diabetes Care (CDC) – Eye Exam (Retinal) Performed
- Exclusions
Show
• Medicare members 66 years of age and older as of December 31 of the measurement year who meet either of the following: – Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. – Living long-term in an institution any time during the measurement year as identified by the LTI flag in the Monthly Membership Detail Data File. • Members 66 years of age and older as of December 31 of the measurement year (all product lines) with frailty (Frailty Value Set) and advanced illness during the measurement year. (optional) Members who do not have a diagnosis of diabetes (Diabetes Value Set), in any setting, during the measurement year or the year prior to the measurement year and who had a diagnosis of gestational diabetes or steroid-induced diabetes (Diabetes Exclusions Value Set), in any setting, during the measurement year or the year prior to the measurement year. Organizations that apply optional exclusions must exclude members from the denominator for all indicators. The denominator for all rates must be the same, with the exception of the HbA1c Control (<7.0%) for a Selected Population denominator. If the member was included in the measure based on claim or encounter data, as described in the event/ diagnosis criteria, the optional exclusions do not apply because the member had a diagnosis of diabetes. Contracts whose enrollment was at least 500 but less than 1,000 as of the July 2020 enrollment report and having measure score reliability less than 0.7 are excluded. Contracts whose enrollment was less than 500 as of the July 2020 enrollment report are excluded from this measure.- Disaster policy
- Higher measure star (2021-2022) for contracts with 25% or more enrolled affected by 2020 disasters.
From the 2022 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.
How the 2028 cut points are projected
Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.
| Stars | Org type | 2027 | Projected 2028 | Move |
|---|---|---|---|---|
| 2★ | MA | 61 | 64 | +3 |
| 3★ | MA | 72 | 74 | +2 |
| 4★ | MA | 79 | 79 | 0 |
| 5★ | MA | 86 | 86 | 0 |
2022 star distribution
Not rated: Plan too new to be measured (152); Plan too small to be measured (80); Plan not required to report measure (63); No data available (45); Not enough data available (7)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA | < 61 % | >= 61 % to < 72 % | >= 72 % to < 79 % | >= 79 % to < 86 % | >= 86 % |
| 2026 | MA | < 60 % | >= 60 % to < 72 % | >= 72 % to < 80 % | >= 80 % to < 86 % | >= 86 % |
| 2025 | MA | < 57 % | >= 57 % to < 70 % | >= 70 % to < 77 % | >= 77 % to < 83 % | >= 83 % |
| 2024 | MA | < 52 % | >= 52 % to < 65 % | >= 65 % to < 73 % | >= 73 % to < 81 % | >= 81 % |
| 2023 | MA | < 47 % | >= 47 % to < 61 % | >= 61 % to < 71 % | >= 71 % to < 79 % | >= 79 % |
| 2022 | MA | < 52 % | >= 52 % to < 62 % | >= 62 % to < 71 % | >= 71 % to < 79 % | >= 79 % |
| 2021 | MA | < 63% | >= 63% to < 69% | >= 69% to < 73% | >= 73% to < 78% | >= 78% |
| 2020 | MA | < 63% | ? 63% to < 69% | ? 69% to < 73% | ? 73% to < 78% | ? 78% |
| 2019 | MA | < 56% | ? 56% to < 64% | ? 64% to < 73% | ? 73% to < 80% | ? 80% |
| 2018 | MA | < 47% | ? 47% to < 59% | ? 59% to < 72% | ? 72% to < 81% | ? 81% |
| 2017 | MA | < 46% | ? 46% to < 61% | ? 61% to < 73% | ? 73% to < 81% | ? 81% |
| 2016 | MA | < 53% | ? 53% to < 65% | ? 65% to < 75% | ? 75% to < 82% | ? 82% |
| 2015 | MA | < 53% | ? 53% to < 60% | ? 60% to < 64% | ? 64% to < 77% | ? 77% |
Lowest-scoring contracts, 2022
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H0982 Solis Health Plans | Athena Healthcare Holdings, LLC | 26,276 | 24 | 1 | — | 47 | 0% |
| H1924 Lasso Healthcare | Zing Health Consolidator, Inc | — | 35 | 1 | — | 36 | 0% |
| H8293 Clear Spring Health | Group 1001 | — | 36 | 1 | — | 35 | 0% |
| H2793 Imperial Insurance Companies, Inc | Imperial Health Plan of California | — | 39 | 1 | — | 32 | 1% |
| H7175 Wellcare | Centene Corporation | — | 41 | 1 | — | 30 | 1% |
| H4091 Simpra Advantage | Associated Care Ventures, Inc. | 3,553 | 42 | 1 | 0 | 29 | 1% |
| H5496 Imperial Health Plan of California, Inc. | Imperial Health Plan of California | 54,253 | 42 | 1 | — | 29 | 1% |
| H1947 Healthy Blue | Elevance Health, Inc. | 3,486 | 43 | 1 | — | 28 | 1% |
| H5199 Wellcare | Centene Corporation | — | 46 | 1 | — | 25 | 2% |
| H9706 Blue Cross and Blue Shield of Texas | Health Care Service Corporation | 6,237 | 47 | 1 | — | 24 | 2% |
| H7323 Wellcare | Centene Corporation | 2,017 | 47 | 1 | — | 24 | 2% |
| H1375 UnitedHealthcare | UnitedHealth Group, Inc. | — | 47 | 1 | — | 24 | 2% |
| H2915 Wellcare | Centene Corporation | 14,346 | 48 | 1 | — | 23 | 2% |
| H0724 Wellcare | Centene Corporation | 0 | 49 | 1 | 0 | 22 | 3% |
| H8554 Blue Cross and Blue Shield of OK, TX | Health Care Service Corporation | 775 | 49 | 1 | 0 | 22 | 3% |
| H7123 UPMC for Life Complete Care | UPMC Health System | 1,546 | 50 | 1 | — | 21 | 3% |
| H8211 UnitedHealthcare | UnitedHealth Group, Inc. | 17,243 | 50 | 1 | 0 | 21 | 3% |
| H3800 Provider Partners Health Plans | Rifkin Managed Care Holding, LLC | 1,079 | 51 | 1 | — | 20 | 3% |
| H4922 AgeWell New York | ParkerCare New York, LLC | — | 52 | 2 | 0 | 19 | 4% |
| H9877 Virginia Premier | Sentara Health Care (SHC) | — | 52 | 2 | +1 | 19 | 4% |
| H1692 Aetna Medicare | CVS Health Corporation | 21,626 | 53 | 2 | +1 | 18 | 4% |
| H9276 Allwell | Centene Corporation | — | 53 | 2 | 0 | 18 | 4% |
| H0111 Wellcare | Centene Corporation | 6,204 | 55 | 2 | +1 | 16 | 4% |
| H2879 Molina Healthcare of Wisconsin and Massachusetts | Molina Healthcare, Inc. | — | 55 | 2 | +1 | 16 | 4% |
| H1914 Wellcare | Centene Corporation | 10,826 | 55 | 2 | — | 16 | 4% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | C11 | Diabetes Care – Eye Exam | 01/01/2025 – 12/31/2025 | 1 | HEDIS |
| 2026 | C11 | Diabetes Care – Eye Exam | 01/01/2024 – 12/31/2024 | 1 | HEDIS |
| 2025 | C09 | Diabetes Care – Eye Exam | 01/01/2023 – 12/31/2023 | 1 | HEDIS |
| 2024 | C09 | Diabetes Care – Eye Exam | 01/01/2022 – 12/31/2022 | 1 | HEDIS |
| 2023 | C09 | Diabetes Care – Eye Exam | 01/01/2021 – 12/31/2021 | 1 | HEDIS |
| 2022 | C09 | Diabetes Care – Eye Exam | 01/01/2020 – 12/31/2020 | 1 | HEDIS |
| 2021 | C13 | Diabetes Care – Eye Exam | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2020 | C13 | Diabetes Care – Eye Exam | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2019 | C13 | Diabetes Care – Eye Exam | 01/01/2017 – 12/31/2017 | 1 | HEDIS |
| 2018 | C13 | Diabetes Care – Eye Exam | 01/01/2016 – 12/31/2016 | 1 | HEDIS |
| 2017 | C13 | Diabetes Care – Eye Exam | 01/01/2015 - 12/31/2015 | 1 | HEDIS |
| 2016 | C13 | Diabetes Care – Eye Exam | 01/01/2014 - 12/31/2014 | 1 | HEDIS |
| 2015 | C14 | Diabetes Care – Eye Exam | 01/01/2013 - 12/31/2013 | 1 | HEDIS |